Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
VIRGINIA RETIREMENT SYSTEMS ET Al Grows Stake in AbbVie Inc. $ABBV
VIRGINIA RETIREMENT SYSTEMS ET Al increased its holdings in AbbVie Inc. by 48.9% in the third quarter, acquiring 96,200 additional shares to reach a total of 293,111 shares valued at $67.9 million. This move comes as AbbVie reported strong Q3 earnings, beating analyst estimates with $1.86 EPS and $15.78 billion in revenue, prompting an increase in its quarterly dividend to $1.73. Institutional ownership of AbbVie stands at 70.23%, with major firms like Vanguard and Geode Capital Management also increasing their positions, and analysts maintaining a "Moderate Buy" consensus with a $245.84 target price.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
AbbVie Inc. $ABBV Shares Acquired by Smith Salley Wealth Management
Smith Salley Wealth Management increased its holdings in AbbVie Inc. by 3.2% in the third quarter, now owning 158,917 shares valued at $36.8 million. Other institutional investors have also adjusted their stakes, with hedge funds and institutional investors collectively owning 70.23% of the company's stock. AbbVie recently reported strong earnings, beating consensus estimates, and announced an increased quarterly dividend of $1.73 per share, representing a 3.0% yield.
Dec 31, 2025 • MarketBeat
BULLISH
Generate Investment Management Ltd Increases Position in AbbVie Inc. $ABBV
Generate Investment Management Ltd has significantly increased its holdings in AbbVie Inc. (NYSE:ABBV) by 91.8% in the third quarter, bringing its total ownership to 86,669 shares valued at $20.07 million. This move comes as other institutional investors have also adjusted their positions in the pharmaceutical giant. AbbVie recently reported strong quarterly earnings, surpassing analyst estimates, and increased its quarterly dividend payment, signaling positive financial health and a commitment to shareholder returns.
Dec 31, 2025 • MarketBeat
SOMEWHAT-BULLISH
Simplify Asset Management Inc. Boosts Stock Holdings in AbbVie Inc. $ABBV
Simplify Asset Management Inc. significantly increased its stake in AbbVie Inc. by 100.6% in the third quarter, now holding 36,883 shares valued at $8.54 million. AbbVie maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $245.84, and recently announced a quarterly dividend increase to $1.73 per share. Despite the dividend increase, the company's dividend payout ratio is noted as unusually high at approximately 497%.
Dec 31, 2025 • MarketBeat
BULLISH
AbbVie Inc. $ABBV Shares Purchased by Brendel Financial Advisors LLC
Brendel Financial Advisors LLC significantly increased its stake in AbbVie Inc. ($ABBV) by 248.4% in Q3, making AbbVie its third-largest holding. This comes as AbbVie surpassed Q3 earnings expectations and issued strong Q4 2025 guidance, leading to a consensus "Moderate Buy" rating from analysts. The company also raised its quarterly dividend, though its payout ratio is notably high.
Dec 31, 2025 • MarketBeat
BULLISH
Diversified Trust Co Purchases 10,891 Shares of AbbVie Inc. $ABBV
Diversified Trust Co increased its stake in AbbVie Inc. (NYSE:ABBV) by 23.6% in the third quarter, acquiring an additional 10,891 shares and bringing its total holdings to 57,076 shares valued at $13.215 million. Other institutional investors also adjusted their positions in ABBV. The article also details AbbVie's stock performance, recent earnings, dividend increase, and updated analyst ratings.